Freestone Grove Partners’s Arcosa ACA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-1,756
Closed -$186K 995
2026
Q1
$186K Buy
+1,756
New +$200K ﹤0.01% 746
2025
Q2
Sell
-7,272
Closed -$561K 649
2025
Q1
$561K Sell
7,272
-2,485
-25% -$228K 0.01% 398
2024
Q4
$944K Buy
+9,757
New +$981K 0.01% 303

Other funds holding ACA

Freestone Grove Partners's ACA Position: Q2 2026 in Review

Freestone Grove Partners sold out of Arcosa (ACA) in Q2 2026, closing a stake of 1,756 shares — an estimated $186K sold.

Freestone Grove Partners first reported a position in ACA in Q4 2024 and held it in 3 quarters. The position peaked at $944K in Q4 2024. 425 funds tracked by Wall St. Rank hold ACA as of Q2 2026.

  • Freestone Grove Partners reported no remaining Arcosa position as of Q2 2026 after selling out during the quarter.
  • Freestone Grove Partners sold 1,756 Arcosa shares in Q2 2026, an estimated $186K.
  • Freestone Grove Partners first reported a position in Arcosa in Q4 2024 and held it in 3 quarters.
  • Freestone Grove Partners's Arcosa position peaked at $944K in Q4 2024.
  • 425 funds tracked by Wall St. Rank held Arcosa as of Q2 2026.

Based on Freestone Grove Partners's 13F filing for Q2 2026, filed 14 Aug 2026.